Barclays plc ADR (NYSE:BCS)’s traded shares stood at 2.09 million during the latest session, with the company’s beta value hitting 1.41. At the last check today, the stock’s price was $13.14, to imply an increase of 5.37% or $0.67 in intraday trading. The BCS share’s 52-week high remains $12.96, putting it 1.37% up since that peak but still an impressive 52.59% since price per share fell to its 52-week low of $6.23. The company has a valuation of $47.64B, with an average of 10.0 million shares in intraday trading volume over the past 10 days and average of 13.81 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Barclays plc ADR (BCS), translating to a mean rating of 1.71. Of 5 analyst(s) looking at the stock, 0 analyst(s) give BCS a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 5 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.43.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Barclays plc ADR (NYSE:BCS) trade information
After registering a 5.37% upside in the latest session, Barclays plc ADR (BCS) has traded red over the past five days. The 5-day price performance for the stock is 1.55%, and 9.77% over 30 days. With these gigs, the year-to-date price performance is 66.75%. Short interest in Barclays plc ADR (NYSE:BCS) saw shorts transact 5.02 million shares and set a 0.3 days time to cover.
Barclays plc ADR (BCS) estimates and forecasts
Looking at statistics comparing Barclays plc ADR share performance against respective industry, we note that the company has outperformed competitors. Barclays plc ADR (BCS) shares are 26.83% up over the last 6 months, with its year-to-date growth rate higher than industry average at 20.29% against 5.10%. The rating firms project that company’s revenue will grow 2.70% compared to the previous financial year.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 22.49% for the past 5-year period. While 2024 is set for a 26.82% return in earnings, projections for the next 5 years are at 2.10% annually.
BCS Dividends
Barclays plc ADR has its next earnings report out on 2024-Oct-24. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Barclays plc ADR has a forward dividend ratio of 0.42, with the share yield ticking at 3.21% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 2.97%.
Barclays plc ADR (NYSE:BCS)’s Major holders
In total, 5.47% institutions holds shares in the company, led by ARROWSTREET CAPITAL, LIMITED PARTNERSHIP. As of 2024-06-30, the company held over 29.98 million shares (or 0.2001% of shares), all amounting to roughly $321.09 million.
The next major institution holding the largest number of shares is ACADIAN ASSET MANAGEMENT LLC with 19.68 million shares, or about 0.1314% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $210.76 million.
We also have DFA International Value Series and Dimensional ETF Tr-Dimensional International Value ETF as the top two Mutual Funds with the largest holdings of the Barclays plc ADR (BCS) shares. Going by data provided on Jul 31, 2024, DFA International Value Series holds roughly 3.63 shares. This is just over 0.10% of the total shares, with a market valuation of $47.62 million. Data from the same date shows that the other fund manager holds a little less at 3.14, or 0.09% of the shares, all valued at about 41.18 million.
